1. Home
  2. MURA vs BWEN Comparison

MURA vs BWEN Comparison

Compare MURA & BWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MURA
  • BWEN
  • Stock Information
  • Founded
  • MURA 2013
  • BWEN N/A
  • Country
  • MURA Ireland
  • BWEN United States
  • Employees
  • MURA N/A
  • BWEN N/A
  • Industry
  • MURA
  • BWEN Industrial Machinery/Components
  • Sector
  • MURA
  • BWEN Industrials
  • Exchange
  • MURA Nasdaq
  • BWEN Nasdaq
  • Market Cap
  • MURA 45.8M
  • BWEN 43.0M
  • IPO Year
  • MURA N/A
  • BWEN N/A
  • Fundamental
  • Price
  • MURA $2.48
  • BWEN $1.84
  • Analyst Decision
  • MURA Strong Buy
  • BWEN Strong Buy
  • Analyst Count
  • MURA 3
  • BWEN 3
  • Target Price
  • MURA $12.00
  • BWEN $4.50
  • AVG Volume (30 Days)
  • MURA 100.7K
  • BWEN 100.3K
  • Earning Date
  • MURA 08-12-2025
  • BWEN 08-12-2025
  • Dividend Yield
  • MURA N/A
  • BWEN N/A
  • EPS Growth
  • MURA N/A
  • BWEN N/A
  • EPS
  • MURA N/A
  • BWEN N/A
  • Revenue
  • MURA N/A
  • BWEN $142,358,000.00
  • Revenue This Year
  • MURA N/A
  • BWEN $7.86
  • Revenue Next Year
  • MURA N/A
  • BWEN $4.51
  • P/E Ratio
  • MURA N/A
  • BWEN N/A
  • Revenue Growth
  • MURA N/A
  • BWEN N/A
  • 52 Week Low
  • MURA $0.95
  • BWEN $1.41
  • 52 Week High
  • MURA $4.74
  • BWEN $3.69
  • Technical
  • Relative Strength Index (RSI)
  • MURA 45.72
  • BWEN 59.28
  • Support Level
  • MURA $2.41
  • BWEN $1.77
  • Resistance Level
  • MURA $2.55
  • BWEN $1.95
  • Average True Range (ATR)
  • MURA 0.09
  • BWEN 0.09
  • MACD
  • MURA -0.01
  • BWEN -0.00
  • Stochastic Oscillator
  • MURA 28.57
  • BWEN 65.38

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.

Share on Social Networks: